Cafe Serendipity Holdings Stock (OTC: CAFS)

Latest news for Cafe Serendipity Holdings (OTC:CAFS) Stock

Cafe Serendipity Holdings Inc y is a development stage company, still potentially offering a turn-key licensed retail solution for a chain of upscale licensed stores serving the recreational and medical marijuana consumer. However, the Company is also looking for other businesses directions in which to take the Company.

CAFE SERENDIPITY HLDG INC by Cafe Serendipity Holdings, Inc.

Cafe Serendipity Holdings Inc

Baird analyst Brian Skorney initiates coverage on Dyne Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>) with a Outperform rating and announces Price Target of $46.

News

Price Target

Initiation

Analyst Ratings

Baird Initiates Coverage On Dyne Therapeutics with Outperform Rating, Announces Price Target of $46

Baird analyst Brian Skorney initiates coverage on Benitec Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) with a Outperform rating and announces Price Target of $30.

BNTC

Baird Initiates Coverage On Benitec Biopharma with Outperform Rating, Announces Price Target of $30

<h3>Companies Reporting Before The Bell</h3>
• 51 Talk Online Education (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/COE#AMEX">COE</a>) is likely to report earnings for its third quarter. 
<h3>Companies Reporting After The Bell</h3>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Earnings Scheduled For December 13, 2024

Amentum Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMTM#NYSE">AMTM</a>) will release earnings results for its latest quarter, before the <a href="https://www.benzinga.com/quote/AMTM/earnings">opening bell on Tuesday, Dec. 17.</a>
Analysts expect the Chantilly, Virginia-based company to report quarterly earnings at 25 cents per share. Amentum projects to report revenue of $3.41 billion for the recent quarter, according to data from Benzinga Pro.
On Dec. 2, Amentum named Darren Burton as Chief People Officer.
Amentum shares fell 1% to close at $23.61 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/AMTM/analyst-ratings">analysts have rated the company</a> in the recent period.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
<ul>
<li>Raymond James analyst Brian Gesuale initiated coverage on the stock with an Outperform rating and a price target of $30 on Nov. 21. This analyst has an accuracy rate of 71%.</li>
<li>Truist Securities analyst Tobey Sommer initiated coverage on the stock with a Buy rating and a price target of $31 on Oct. 14. This analyst has an accuracy rate of 77%.</li>
</ul>
Considering buying AMTM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="592" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/13032936/image-108-1024x592.png" alt="" class="wp-image-690894" style="width:636px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/13032936/image-108-1024x592.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/13032936/image-108-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/13032936/image-108-768x444.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/13032936/image-108.png 1100w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42460676/jim-cramer-amd-ceo-lisa-su-built-an-amazing-company">Jim Cramer Says This CEO &#8216;Built An Amazing Company,&#8217; Recommends Buying Netflix</a></li>
</ul>

Markets

Trading Ideas

AMTM

Amentum Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the &#8220;Neutral&#8221; zone on Thursday.
U.S. stocks settled lower on Thursday, with the Dow Jones index falling more than 200 points following the release of inflation data.
Tech stocks were among the notable decliners, with shares of Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) falling over 1% on Thursday. Adobe Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) shares fell over 13% after the company issued weaker-than-expected 2025 guidance.
On the economic data front, U.S. initial jobless claims increased by 17,000 from the previous week to a reading of 242,000 during the first week of December, compared to market estimates of 220,000. Core producer prices increased by 0.2% month-over-month in November compared to a 0.3% increase in the previous month, which is in line with market expectations.
Most sectors on the S&amp;P 500 closed on a negative note, with healthcare, consumer discretionary, and communication services stocks recording the biggest losses on Thursday. However, consumer staples stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 234 points to 43,914.12 on Thursday. The S&amp;P 500 fell 0.54% to 6,051.25, while the Nasdaq Composite dipped 0.66% to close at 19,902.84 during Thursday's session.
Investors are awaiting earnings results from 51Talk Online Education Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COE#NYSE">COE</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 48.6, the index remained in the &#8220;Neutral&#8221; zone on Thursday, versus a prior reading of 51.7.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42460676/jim-cramer-amd-ceo-lisa-su-built-an-amazing-company">Jim Cramer Says This CEO &#8216;Built An Amazing Company,&#8217; Recommends Buying Netflix</a></li>
</ul>
Photo courtesy: Shutterstock

Pre-Market Outlook

ADBE

NVDA

Dow Dips More Than 200 Points Following Inflation Data, Nvidia And AMD Decline: Fear & Greed Index Remains In 'Neutral' Zone

An Arizona man posing as an Uber driver allegedly stole over $300,000 in cryptocurrency from unsuspecting passengers, according to a report on Thursday. 
What Happened: The accused, Nuruhussein Hussein, pretended to be an Uber driver and picked up people waiting at a Scottsdale hotel, FOX 10 Phoenix <a href="https://www.fox10phoenix.com/news/fake-uber-driver-allegedly-stole-thousands-crypto-from-customers">reported</a>, citing the Scottsdale Police Department. 
The alleged scam began with Hussein calling out the names of potential Uber passengers he witnessed waiting for their rides.
Authorities alleged that Hussein asked his passengers to unlock their phones and hand them over to him to help troubleshoot when the app did not recognize him as the driver. Once in control of the victims&#8217; devices, he deceitfully transferred funds from their digital wallets to his own, with the total amount stolen estimated to be around $302,000.
Court documents indicated that one victim handed over his phone to Hussein in October, who drove a short distance before returning the phone, claiming he was unable to connect the ride. The victim later&nbsp;noticed several emails indicating a&nbsp;cryptocurrency transfer had occurred.
Hussein was booked into Maricopa County jail for multiple felony charges, including theft, fraud schemes, and money laundering. The investigation, involving&nbsp;Scottsdale police detectives and Secret&nbsp;Service Special Agents, is ongoing.
See Also:&nbsp;<a href="https://www.benzinga.com/24/12/42477447/dogecoins-fate-tied-to-bitcoin-not-worth-overly-focusing-on-analyst-says-as-apex-memecoin-mirrors-btcs-pullback">Dogecoin&#8217;s Fate Tied To Bitcoin, Says Crypto Analyst: &#8216;Sit Back And Wait&#8217;</a>
Why It Matters: This incident underscores the growing concern over the security of digital assets and the ease with which they can be stolen. 
Last month, a Colorado resident was tricked into sending $6,000 worth of&nbsp;Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) to f<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41707301/woman-loses-thousands-in-bitcoin-after-fake-sheriffs-dupe-her-into-clearing-fraud-arrest-w">ake law enforcement officials.</a>
The scammers threatened the victim with arrest for supposedly missing jury duty. The victim, under the impression that she had missed a jury summons, followed the scammer's instructions to settle a fake warrant via a Bitcoin ATM.
Earlier in August, the Federal Bureau of Investigation (FBI) sounded the alarm on incidents of <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40132699/fbi-issues-alert-on-crypto-exchange-impersonation-scams" target="_blank" rel="noreferrer noopener">scammers impersonating cryptocurrency exchange employees</a> to defraud people.
Photo via Shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/12/42477105/trump-linked-world-liberty-financials-purchases-have-aave-and-chainlink-topping-crypto-gainers-list">Trump-Linked World Liberty Financial&#8217;s Purchases Induce Searing Hot Rally In Aave And Chainlink</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Fake Uber Driver Takes Passengers For A Ride By Stealing Crypto Over $300K

Nyxoah Announces Commercial Launch of Genio&#xAE; Innovative Therapy in England First patients implanted with Genio at UCLH, London

NYXH

Nyxoah's Genio Neuromodulation Therapy Debuts In England With First Implants At UCLH Under NHS Coverage

While Gravity is divesting its water midstream assets, the company will retain ownership and operation of its power infrastructure assets, continuing its commitment to providing critical power generation offerings.
Clearlake and Gravity partnered in 2017 to pursue produced water midstream opportunities. Over the last several years, Gravity has focused on organically growing its water infrastructure business to support producers in the Midland and Williston basins, and its water business segment has quickly grown into one of the largest commercial operators of disposal wells in the Midland Basin. Gravity Water Midstream developed a system comprised of 200+ miles of permanent pipeline, 46 SWD facilities,&nbsp;and 14 fresh water facilities with over six million barrels of storage capacity, all of which form an extensive and interconnected network.

Reported Earlier, Delek Logistics Acquires Gravity Water Midstream's 200+ Mile Pipeline Network And Extensive Water Infrastructure In The Midland Basin

Equity Swap Settlement: cash settlement, within a maximum period of 12 months from December 13, 2024.
Maximum Exposure: up to 16,156,597 common shares, observing the limit established in CVM Resolution No. 77/22.
Conditions: the Equity Swap will allow the Company to receive the price variation related to its shares traded on the stock exchange plus any dividends distributed to the shares subject to the Equity Swap (active end) and pay CDI plus a fee (passive end), during the term of the agreement.
Purpose: need to mitigate fluctuations in the prices of shares issued by the Company, in view of future payments to be made by the Company within the scope of its long-term incentive plans.

Embraer-Empresa Brasileira De Aeronautica

Reported Earlier, Embraer Approves Equity Swap Agreements With Banco Itaú BBA To Stabilize Share Prices For Long-Term Incentive Plans

AGMH

Reported Earlier, AGM Group Holdings Acquires 2,000 Bitcoin Mining Machines, Secures Option For 30,000 More In Long-Term Crypto Strategy

<ul>
<li>Topline combination data for zelenectide pevedotin plus pembrolizumab in first-line metastatic urothelial cancer demonstrated a 60% overall response rate, in line with existing therapies</li>
<li>Dose selection and topline data from Phase 2/3 Duravelo-2 trial planned for 2H 2025</li>
<li>Heavily pretreated breast cancer and non-small cell lung cancer patients with NECTIN4 gene amplification and/or polysomy demonstrated an enhanced response to zelenectide pevedotin</li>
<li>Company to advance development strategy leveraging NECTIN4 gene amplification, with Phase 1/2 trials in breast cancer, lung cancer and multi-tumor planned for 2025</li>
<li>Bicycle Therapeutics to host conference call and webcast with management and oncology experts on Friday, Dec. 13, at 8 a.m. ET</li>
</ul>

BCYC

Reported Earlier, Bicycle Therapeutics Unveils Topline Data For Zelenectide Pevedotin In Combination And Monotherapy, Expanding Focus On NECTIN4 Cancers

Macro Economic Events

Econ #s

Economics

France Harmonised Index of Consumer Prices (MoM) For November 0.3% Vs. -0.1% Est.; 0.3% Prior

France Consumer Price Index (MoM) For November -0.1% Vs. 0.1% Est.; 0.3% Prior

ACOG

Reported Earlier, Alpha Cognition To Voluntarily Delist From Canadian Securities Exchange On December 17, 2024

US$10 million milestone payment to HUTCHMED follows first national reimbursement in Europe&nbsp;—
— Follows June 2024 European approval of FRUZAQLA&#xAE; (fruquintinib), the first novel oral targeted therapy in the EU for metastatic colorectal cancer regardless of biomarker status in over a decade&nbsp;—

Reported Earlier, HUTCHMED to Receive $10M Payment From Takeda As FRUZAQLA Achieves First National Reimbursement In Europe For Metastatic Colorectal Cance

SYH2039 targets solid tumors that have a mutation called MTAP deletion, which is estimated to be present in approximately 15 percent of all cancer types with the most common including glioblastoma, pancreatic cancer and non-small cell lung cancer.
"With one of the most dynamic solid tumor portfolios in the industry, we are continually assessing opportunities that align with our strategic focus and address significant unmet needs for patients. This MAT2A inhibitor is a valuable addition to our solid tumor pipeline, and we're eager to explore its potential, particularly in combination with our internally developed PRMT5 inhibitor, BGB-58067. Together, these assets hold promise for advancing treatment across a range of solid tumors," said Lai Wang, Ph.D., Global Head of R&amp;D at BeiGene.

BGNE

Reported Earlier, BeiGene Secures Global Licensing Agreement For Novel MAT2A Inhibitor SYH2039 To Target MTAP-Deleted Solid Tumors

Investigation Details: The Company has uncovered evidence suggesting that Yi Zhang, during his tenure in key executive roles, misappropriated corporate assets for personal gain and mismanaged the Company, resulting in significant financial losses over past several years, thereby seriously harming the interests of shareholders of the Company.
Corrective Actions: In response to these revelations, by March 2024, the Company took decisive action to remove Yi Zhang from all executive positions within the Company and its subsidiaries, in accordance with the Company's Memorandum and Articles of Association effective at that time and relevant laws. This action was necessary to mitigate the damage caused by Yi Zhang and his associates. Under the new leadership, the Company's financial and operational performance has seen a marked improvement. The Company has achieved smooth operations, secured second position in China's Rabies vaccine market and reaffirmed the full year financial guidance through Fiscal Year 2025 ended March 31, 2025.

Comments

Cafe Serendipity Holdings

News

Latest news for Cafe Serendipity Holdings (OTC:CAFS) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga